Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma
Clinical trial NCT02481960 · TERMINATED
Trial details
- NCT number
- NCT02481960
- Sponsor
- Boston Scientific Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-21
- Primary completion
- 2015-12-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.